Human Galectin-3BP/MAC-2BP Antibody, R&D Systems™

Galectin-3BP/MAC-2BP/LGALS3BP

Polyclonal

Unconjugated

Q08380

LGALS3BP

Mouse myeloma cell line NS0-derived recombinant human Galectin-3BP/MAC-2BP Val19-Asp585 Accession # Q08380

100 μg

Primary

Detects human Galectin-3BP/MAC-2BP in direct ELISAs and Western blots. In direct ELISAs, no cross-reactivity with recombinant human (rh) Galectin-1, rhGalectin-2, rhGalectin-7, rhGalectin-8, rhGalectin-9, and recombinant mouse (rm) Galectin-1 is observed. In direct ELISAs, approximately 1% cross-reactivity with rmGalectin-9, approximately 8% cross-reactivity with rmGalectin-3, and approximately 15% cross-reactivity with rmMAC-2BP is observed. In Western blots, approximately 15% cross-reactivity with recombinant mouse MAC-2BP is observed.

Human

IgG

Western Blot, Immunocytochemistry

LYOPH

Western Blot 0.2 ug/mL, Simple Western 10 ug/mL, Immunocytochemistry 1-15 ug/mL

90K, Basement membrane autoantigen p105, BTBD17B, galectin-3-binding protein, Galectin3BP, L3 antigen, Lectin galactoside-binding soluble 3-binding protein, lectin, galactoside-binding, soluble, 3 binding protein, LGALS3BP, M2BP, Mac-2 BP, Mac-2-binding protein, MAC2BP, MAC-2BP, MAC-2-BP, serum protein 90K, Tumor-associated antigen 90K

Goat

Affinity Purified

RUO

3959

Reconstitute at 0.2 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.